These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10510206)

  • 1. Cell biology of Paget's disease.
    Reddy SV; Menaa C; Singer FR; Demulder A; Roodman GD
    J Bone Miner Res; 1999 Oct; 14 Suppl 2():3-8. PubMed ID: 10510206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
    Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
    J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
    Neale SD; Smith R; Wass JA; Athanasou NA
    Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
    Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
    J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.
    Kukita A; Chenu C; McManus LM; Mundy GR; Roodman GD
    J Clin Invest; 1990 Apr; 85(4):1280-6. PubMed ID: 2318982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease.
    Demulder A; Takahashi S; Singer FR; Hosking DJ; Roodman GD
    Endocrinology; 1993 Nov; 133(5):1978-82. PubMed ID: 7691583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
    Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of Paget's disease and osteoclast abnormalities.
    Reddy SV
    J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
    Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
    Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoclast function in Paget's disease and multiple myeloma.
    Roodman GD
    Bone; 1995 Aug; 17(2 Suppl):57S-61S. PubMed ID: 8579899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
    Roodman GD; Kurihara N; Ohsaki Y; Kukita A; Hosking D; Demulder A; Smith JF; Singer FR
    J Clin Invest; 1992 Jan; 89(1):46-52. PubMed ID: 1729280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
    Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
    J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paget's disease-a VDR coactivator disease?
    Kurihara N; Ishizuka S; Demulder A; Menaa C; Roodman GD
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):321-5. PubMed ID: 15225793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of bone: a disease of the osteoclast.
    Reddy SV; Kurihara N; Menaa C; Roodman GD
    Rev Endocr Metab Disord; 2001 Apr; 2(2):195-201. PubMed ID: 11705325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens.
    Mills BG; Frausto A; Singer FR; Ohsaki Y; Demulder A; Roodman GD
    Bone; 1994; 15(4):443-8. PubMed ID: 7917585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease.
    Neale SD; Schulze E; Smith R; Athanasou NA
    QJM; 2002 Apr; 95(4):233-40. PubMed ID: 11937650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paget's disease and osteoclast biology.
    Roodman GD
    Bone; 1996 Sep; 19(3):209-12. PubMed ID: 8873960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
    Reddy SV; Kurihara N; Menaa C; Landucci G; Forthal D; Koop BA; Windle JJ; Roodman GD
    Endocrinology; 2001 Jul; 142(7):2898-905. PubMed ID: 11416009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
    Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
    J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
    Teramachi J; Hiruma Y; Ishizuka S; Ishizuka H; Brown JP; Michou L; Cao H; Galson DL; Subler MA; Zhou H; Dempster DW; Windle JJ; Roodman GD; Kurihara N
    J Bone Miner Res; 2013 Jun; 28(6):1489-500. PubMed ID: 23426901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.